Up To 50 SAR OFF Your First Order Use Code : APP50 | Get Free Delivery With No Minimum Order

Frequently bought together
FEVADOL 200/MG SUPP FOR CHILDREN 10/SUPP
- Sku : I-002228
Key features
FEVADOL 200 mg suppositories for children contain paracetamol 200 mg per suppository. It exerts analgesic and antipyretic effects primarily through central inhibition of prostaglandin synthesis (COX activity) and modulation of pain pathways, with antipyretic action mediated at the hypothalamic heat‑regulating center. It is indicated for the symptomatic relief of fever and mild-to-moderate pain in children. Available over-the-counter in a pack of 10 suppositories.- Brand: FEVADOL
- Active Ingredient: PARACETAMOL 200mg
- Strength: 200mg
- Dosage Form: Suppository
- Pack Size: 10 Suppositories
- Route: Rectal use
- Prescription Status: OTC
- Therapeutic Class: Analgesic
- Pharmacological Group: Anilides (Paracetamol)
- Drug Class: Non-opioid analgesic and antipyretic (anilide/para-aminophenol derivative); ATC N02BE01.
- Manufacturer: SPIMACO
- Country of Origin: Saudi Arabia
- SFDA Registration No.: 2307257827
- Shelf Life: 36 months
- Storage: store below 25°c
- Pain Type: General
- Nsaid: No
- Opioid: No
Frequently bought together
Indications
Approved Uses
Symptomatic treatment of fever and mild-to-moderate pain in children.
Dosage & Administration
Dosing by Condition
Children (fever or mild-moderate pain): 10-15 mg/kg per dose rectally every 4-6 hours as needed; do not exceed 60 mg/kg/day (or 4 doses/24 h, whichever is lower) unless directed by a clinician.
Initial Dose
10-15 mg/kg per dose rectally
Maintenance Dose
10-15 mg/kg every 4-6 hours as needed
Maximum Dose
Rectal (children): 10-15 mg/kg per dose every 4-6 hours as needed; maximum 60 mg/kg/day (do not exceed 4 doses in 24 hours).
Children's Dosage
10-15 mg/kg/dose rectally every 4-6 hours; for a child weighing ~13-20 kg, one 200mg suppository per dose is appropriate; maximum 4 doses per 24 hours
Dose Adjustment Notes
Hepatic impairment/chronic alcohol exposure: use with caution and avoid exceeding recommended total daily dose; severe hepatic disease requires medical supervision. Renal impairment: if severe (e.g., CrCl <30 mL/min), extend dosing interval (e.g., every 6-8 hours) and keep within maximum daily dose.
How to Take
For rectal use only: wash hands, remove suppository from blister, insert gently into the rectum (usually pointed end first) while the child is lying on their side; keep the child lying for a few minutes to reduce expulsion (you may hold the buttocks together briefly if needed), then wash hands again.
Side Effects
Common Side Effects
Usually well tolerated; possible local rectal irritation (redness, soreness, discomfort) and occasional gastrointestinal upset (e.g., nausea).
Side Effect Frequency
Rectal irritation (e.g., local redness/soreness) is uncommon; hypersensitivity reactions (rash/urticaria) are rare; serious skin reactions (SJS/TEN) and blood dyscrasias are very rare; clinically significant liver injury is rare at recommended doses (risk increases with overdose or predisposing factors).
Safety & Warnings
Contraindications
Hypersensitivity to paracetamol (acetaminophen) or excipients; severe hepatic impairment/active liver disease.
Warnings & Precautions
Do not exceed recommended dose; avoid concurrent use with other paracetamol-containing products; use caution in hepatic disease, chronic alcohol use/malnutrition, and renal impairment; stop and seek care if rash/allergy occurs; if fever/pain persists >3 days (or worsens), consult a clinician.
Age Restriction
Pediatric use; 200 mg suppository is typically appropriate for children about 12-20 kg (≈2-6 years) using weight-based dosing (10-15 mg/kg/dose every 4-6 hours; max 60 mg/kg/day). For infants <3 months, use only on medical advice.
Drug Interactions
Drug Interactions
Warfarin (↑INR with repeated/prolonged use), enzyme inducers (carbamazepine, phenytoin, phenobarbital, rifampicin) and isoniazid (↑hepatotoxicity risk), alcohol/chronic ethanol use (↑hepatotoxicity risk), cholestyramine (↓absorption-mainly relevant to oral), metoclopramide/domperidone (↑absorption-oral only; not clinically relevant for rectal).
Interaction Severity
MAJOR/clinically significant: chronic heavy alcohol use or other hepatotoxic risk factors (increased hepatotoxicity risk). MODERATE: warfarin with regular/repeated paracetamol use (can increase INR/bleeding risk); isoniazid (hepatotoxicity risk); enzyme inducers such as carbamazepine, phenytoin, phenobarbital (hepatotoxicity risk). MINOR: cholestyramine can reduce absorption of oral paracetamol (separate dosing; not relevant to rectal route).
Food Interaction
No restriction
Special Populations
Children
10-15 mg/kg/dose rectally every 4-6 hours; for a child weighing ~13-20 kg, one 200mg suppository per dose is appropriate; maximum 4 doses per 24 hours
Storage & Patient Advice
Missed Dose
If used on a schedule, give as soon as remembered; if near the next dose, skip the missed dose and continue the regular schedule-do not double the dose. If used as needed, give the next dose when needed while respecting minimum intervals and maximum daily dose.
Stopping the Medicine
No taper required. May stop when symptoms resolve; do not exceed recommended dose/frequency and seek medical advice if fever persists >3 days or pain >5 days.
Overdose
Overdose may have minimal symptoms initially (first 24 h: nausea/vomiting/diaphoresis), followed by delayed hepatotoxicity at 24-72 h; seek urgent medical care immediately even if asymptomatic; management includes early activated charcoal (if appropriate) and N-acetylcysteine (NAC) guided by nomogram/clinical assessment.
Patient Counseling
Rectal use only; dose by the child’s weight and keep at least 4-6 hours between doses; do not exceed 4 doses in 24 hours (or the product/clinician maximum). Do not use with any other paracetamol-containing medicine. Insert gently and keep the child lying briefly to reduce expulsion. Store below 25°C. Seek medical advice if fever persists >3 days, pain persists >5 days, the child is very young or symptoms worsen; seek urgent help for suspected overdose even if the child seems well.
Monitoring Requirements
No routine monitoring required for short-term use. Liver function tests may be needed for long-term use or in patients with liver disease.
Pharmacology
Mechanism of Action
Analgesic/antipyretic action primarily via central inhibition of prostaglandin synthesis (COX activity) and modulation of pain pathways; antipyresis via hypothalamic heat-regulating center leading to increased heat dissipation.
Duration of Effect
4-6 hours
Half-Life
Approximately 2 hours (typical range ~1-3 hours in children with normal hepatic function).
Bioavailability
Rectal bioavailability is variable and generally lower/less predictable than oral, often cited around ~30-60% depending on formulation and placement (not reliably 63-89%).
Metabolism
Hepatic metabolism mainly via glucuronidation and sulfation; a minor pathway via CYP (notably CYP2E1) forms NAPQI, which is detoxified by glutathione at therapeutic doses.
Excretion
Primarily renal excretion (>90%) as inactive glucuronide and sulfate conjugates; a small fraction is excreted unchanged in urine.
Protein Binding
10-25%
Product Information
Available Dosage Forms
Suppository (rectal) for this specific product (FEVADOL 200 mg).
Composition per Dose
Each suppository: 200mg paracetamol
Generic Availability
Yes
OTC Alternatives
Other OTC paracetamol pediatric formulations (e.g., oral suspension) and ibuprofen oral suspension (age-appropriate, typically ≥3 months) are common alternatives; avoid duplicating paracetamol across products.
Pain Type
General
Nsaid
No
Opioid
No
Legal Disclaimer - Al Mujtama Pharmacy
The product information provided is derived from verified pharmaceutical references and is intended for general health education only. It is not a substitute for professional medical advice, diagnosis, or treatment.
Al Mujtama Pharmacy assumes no legal or medical liability for:
- Any therapeutic decision made based on the information displayed without consulting a licensed physician or pharmacist
- Any discrepancy between the information provided and the product's package insert or SFDA guidelines
- Any misuse of medication resulting from personal interpretation of the content displayed
Important notice: Drug formulations and instructions may vary between production batches. Always rely on the leaflet included inside the product packaging you have, and consult your pharmacist or physician before starting, adjusting, or discontinuing any medication.
By using this content, you acknowledge that you have read this disclaimer and agree that Al Mujtama Pharmacy bears no liability arising from reliance on this information as a substitute for direct medical consultation.
Your health is a trust - always consult your doctor first.
-1744229570.gif)













